Sickle Cell Anemia Clinical Trial
Official title:
Early Detection of Changes in Ventilatory Mechanics in Patients With Sickle Cell Anemia
The Sickle Cell Anemia (SCA) is a recessive genetic condition, monogenic, resulting in
defects in the red cell structure. In the investigators' country, this disease affects about
3,000 children each year and is considered one of the most prevalent disorders among the
group of existing hereditary diseases.
The lungs are frequently affected in this disease by Acute Chest Syndrome (STA). Besides
being the leading cause of death and the second leading cause of hospitalization in SCA, the
STA is correlated with cognitive impairment frame these patients, resulting secondary Stroke
vaso-occlusion of capillaries that supply the brain tissue.
Traditional tests of pulmonary function allow assess whether the person has any commitment
in the respiratory system, whether obstructive, restrictive or mixed. To run these tests it
is necessary that the patient understands and performs a forced expiratory maneuver to
obtain reliable results. In the particular case of SCA, performing these tests it is very
difficult due to the presence of cognitive impairment of varying degrees. This results in
underdiagnosis of early changes in the lung parenchyma during the therapeutic window,
committing the proper monitoring and treatment offered to these patients.
The aim of the present study is to observe the use of the Forced Oscillation Technique (FOT)
in the detection of the alterations of the respiratory mechanical in subjects with Sickle
Cell Anemia. One group of patients with Sickle Cell Anemia was compared with a volunteers
group without pulmonary alterations.
The experimental phase of this research was developed from the University Hospital of the
Pulmonology Department Pedro Ernesto (HUPE) and Laboratory Instrumentation Biomedical of Rio
de Janeiro State University (UERJ) and was approved by the Committee for Ethics in the
Hospital Survey. The Informed Consent was obtained from all volunteers and patients. The
study protocol complies with the Helsinki Declaration and Resolution CNS 466/12.
Patients were recruited from the Hematology clinic of the University Hospital Pedro Ernesto.
After screening of the inclusion criteria, these individuals were referred to the following
tests: Respiratory Function Support and Technical by Forced Oscillations.
The Respiratory Function Test were performed in the Pulmonary Function Testing Laboratory at
the University Hospital Pedro Ernesto and obeyed the standard protocol of the American
Thoracic Society / European Respiratory Society (ATS / ERS).
In clinical exams with the FOT, the volunteers remained seated, his head in the neutral
position and used a nose clip. They were asked to maintain a basal respiration throughout
the examination period through a silicone nozzle, with cheeks sustained by the hands in
order to reduce the shunt effect. The system applies sinusoidal pressure signals emitting
oscillatory waves in the frequency range 4-32 Hz. The results to be considered suitable,
should apre sit coherence function ≥ 0.9. Three measurements were performed for 16 seconds,
with rest interval between them. Finally, to analyze the parameters measured, obtained was
the average of all the results. Among the parameters evaluated the resistive and reactive
parameters of the respiratory system were studied, respectively.
;
Observational Model: Case Control, Time Perspective: Cross-Sectional
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04134299 -
To Assess Safety, Tolerability and Physiological Effects on Structure and Function of AXA4010 in Subjects With Sickle Cell Disease
|
N/A | |
Completed |
NCT04581356 -
Voxelotor Sickle Cell Exercise Study
|
Phase 4 | |
Completed |
NCT02712346 -
The Role of Endothelin-1 in Sickle Cell Disease
|
Phase 1 | |
Withdrawn |
NCT02162225 -
Study of Beet Juice for Patients With Sickle Cell Anemia
|
Phase 2 | |
Completed |
NCT01976416 -
Novel Use Of Hydroxyurea in an African Region With Malaria
|
Phase 3 | |
Completed |
NCT01137721 -
State Of The Art Functional Imaging In Sickle Cell Disease
|
||
Terminated |
NCT01350232 -
Treatment of Sickle Cell Anemia With Stem Cell Transplant
|
N/A | |
Withdrawn |
NCT00937144 -
Endothelial Function in Patients With Sickle Cell Anemia Before and After Sildenafil
|
Phase 4 | |
Completed |
NCT00512564 -
Clinical and Laboratory Assessment of Iron Overload in Sickle Cell Anemia and Sickle Cell Thalassemia
|
N/A | |
Completed |
NCT00512226 -
Iron Overload Assesment in Sickle Cell Anemia and Sickle Cell Thalassemia
|
N/A | |
Completed |
NCT00004143 -
Allogeneic Mixed Chimerism Stem Cell Transplant Using Campath for Hemoglobinopathies & Bone Marrow Failure Syndromes
|
Phase 2 | |
Completed |
NCT00004412 -
Phase II Randomized Trial:Arginine Butyrate Plus Standard Local Therapy in Patients With Refractory Sickle Cell Ulcers
|
Phase 2 | |
Withdrawn |
NCT01925001 -
Phase 2 Study of MP4CO to Treat Vaso-occlusive Sickle Crisis
|
Phase 2 | |
Completed |
NCT01783990 -
Pediatric Hydroxyurea Phase III Clinical Trial (BABY HUG) Follow-up Observational Study II Protocol
|
||
Completed |
NCT01848691 -
Carbon Monoxide Monitor for the Measurement of End-Tidal Carbon Monoxide Levels in Children With or Without Hemolysis
|
N/A | |
Completed |
NCT00874172 -
Effectiveness of New Analgesic Strategy Compared to the Usal Antalgic Strategy
|
N/A | |
Completed |
NCT01000155 -
Efficacy of Vorinostat to Induce Fetal Hemoglobin in Sickle Cell Disease
|
Phase 2 | |
Completed |
NCT00236093 -
Extension Study of ACTIQ Treatment for Children and Adolescents With Breakthrough Pain
|
Phase 2 | |
Completed |
NCT00399074 -
Sulfadoxine- Pyrimethamine Versus Weekly Chloroquine for Malaria Prevention in Children With Sickle Cell Anemia
|
Phase 3 | |
Completed |
NCT00004492 -
Phase I/II Randomized Study of Hydroxyurea With or Without Clotrimazole in Patients With Sickle Cell Anemia
|
Phase 1/Phase 2 |